Login

Financial Snapshot

Revenue
TTM
$4.158B
Gross Margin
TTM
53.94%
Net Income
TTM
$583.6M
Current Assets
2025 Q4
$1.983B
Current Liabilities
2025 Q4
$2.741B
Current Ratio
2025 Q4
72.35%
Total Assets
2025 Q4
$16.35B
Total Liabilities
2025 Q4
$5.494B
Book Value
2025 Q4
10.86B
Cash
2025 Q4
$275.3M
P/E
TTM
296.3
Free Cash Flow
TTM
$750.7M

Stock Price

Loading...
Market Cap: $172.92 Billion

About Novozymes A/S

Novonesis (Novozymes A/S) engages in the era of biosolutions. The firm operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. The company develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Bayer and Syngenta in Agriculture and DSM and Adisseo in Animal Health & Nutrition..

Industry: UNKNOWN

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support